UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 3)*
Panacos Pharmaceuticals, Inc.
---------------------------------------
(Name of Issuer)
Common Stock
---------------------------------------
(Title of Class of Securities)
917920 10 0
---------------------------------------
(CUSIP Number)
Dr. Jeffrey R. Jay, MD
Great Point Partners, LLC
2 Pickwick Plaza, Suite 450
Greenwich, CT 06830
(Name, Address and Telephone Number of Person Authorized to Receive Notices
and Communications)
August 22, 2005
---------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check
the following box [ ].
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purposes of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP No. 917920 10 0 Page 2 of 8
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON Great Point Partners, LLC
S.S. OR I.R.S. IDENTIFICATION NO.
OF ABOVE PERSON
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A (a) [ ]
MEMBER OF A GROUP (b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS Not applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL [ ]
PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, USA
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER 0
SHARES -------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER 4,240,932
OWNED BY -------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER 0
REPORTING -------------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER 4,240,932
WITH
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY 4,240,932
OWNED BY EACH REPORTING PERSON
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN [ ]
ROW (11) EXCLUDES CERTAIN SHARES
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY 10.06%*
AMOUNT IN ROW (11)
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON OO
CUSIP No. 917920 10 0 Page 3 of 8
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON Biomedical Value Fund,
S.S. OR I.R.S. IDENTIFICATION NO. L.P.
OF ABOVE PERSON
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A (a) [ ]
MEMBER OF A GROUP (b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS Not applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL [ ]
PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware, U.S.A
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER 1,904,182
SHARES -----------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER 1,904,182
REPORTING -----------------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER 0
WITH
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY 1,904,182
OWNED BY EACH REPORTING PERSON
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN [ ]
ROW (11) EXCLUDES CERTAIN SHARES
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY 4.66%*
AMOUNT IN ROW (11)
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON PN
CUSIP No. 917920 10 0 Page 4 of 8
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON Biomedical Offshore
S.S. OR I.R.S. IDENTIFICATION NO. Value Fund, Ltd.
OF ABOVE PERSON
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A (a) [ ]
MEMBER OF A GROUP (b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS Not applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL [ ]
PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER 2,336,750
SHARES -----------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER 0
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER 2,336,750
REPORTING -----------------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER 0
WITH
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY 2,336,750
OWNED BY EACH REPORTING PERSON
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN [ ]
ROW (11) EXCLUDES CERTAIN SHARES
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY 5.73%*
AMOUNT IN ROW (11)
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON CO
CUSIP No. 917920 10 0 Page 5 of 8
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON Dr. Jeffrey R. Jay, M.D.
S.S. OR I.R.S. IDENTIFICATION NO.
OF ABOVE PERSON
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A (a) [ ]
MEMBER OF A GROUP (b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS Not applicable
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL [ ]
PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e)
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION United States
--------------------------------------------------------------------------------
NUMBER OF 7 SOLE VOTING POWER 90,625
SHARES -----------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER 4,240,932
OWNED BY -----------------------------------------------------------------
EACH 9 SOLE DISPOSITIVE POWER 90,625
REPORTING -----------------------------------------------------------------
PERSON 10 SHARED DISPOSITIVE POWER 4,240,932
WITH
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY 4,331,557
OWNED BY EACH REPORTING PERSON
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN [ ]
ROW (11) EXCLUDES CERTAIN SHARES
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY 10.27%*
AMOUNT IN ROW (11)
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON IN
* The calculation of the foregoing percentages is based on 39,509,667 shares of
Common Stock outstanding as of July 15, 2005, as reported in the Issuer's
Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission
on August 15, 2005.
CUSIP No. 917920 10 0 Page 6 of 8
AMENDMENT NO. 2 TO
STATEMENT ON SCHEDULE 13D FILED BY
GREAT POINT PARTNERS, LLC.
This Amendment No. 3 amends and supplements Item 5 of the Schedule 13D,
dated March 11, 2005 (the "Schedule 13D") filed by Great Point Partners, LLC
("Great Point"), Biomedical Value Fund, L.P. ("BMVF"), Biomedical Offshore Value
Fund, Ltd. ("BOVF") and Dr. Jeffrey R. Jay, M.D. ("Dr. Jay"), as amended by
Amendment No. 1 thereto filed on July 13, 2005 and Amendment No. 2 thereto filed
on July 22, 2005, with respect to the shares of common stock, par value $0.01
per share (the "Common Stock") of Panacos Pharmaceuticals, Inc. (formerly V.I.
Technologies, Inc.) (the "Issuer").
Item 5 "Interest in Securities of the Issuer" of the Schedule 13D is
hereby amended to add the following information:
Item 5. Interest in Securities of the Issuer.
(a) and (b)
As a result of sales conducted on August 22, 2005, August 23, 2005 and
August 24, 2005, BMVF is now the beneficial owner of 1,904,182 shares of Common
Stock, consisting of 516,884 shares of Common Stock and warrants to purchase
1,387,298 shares of Common Stock. Such shares, in the aggregate, represent 4.66%
of the shares of Common Stock outstanding, computed in accordance with Rule
13d-3. BMVF disclaims beneficial ownership of any securities owned by BOVF or
Dr. Jay.
As a result of sales conducted on August 22, 2005, August 23, 2005 and
August 24, 2005, BOVF is now the beneficial owner of 2,336,750 shares of Common
Stock, consisting of 1,079,000 shares of Common Stock and warrants to purchase
1,257,750 shares of Common Stock. Such shares, in the aggregate, represent 5.73%
of Common Stock outstanding, computed in accordance with Rule 13d-3. BOVF
disclaims beneficial ownership of any securities owned by BMVF or Dr. Jay.
Great Point is the investment manager of each of BMVF and BOVF, and by
virtue of such status has shared voting and investment power with respect to
securities owned and held by BMVF and BOVF and may be deemed to be the
beneficial owner of such securities. Thus, as a result of the August 22, 2005,
August 23, 2005 and August 24, 2005 sales described above, Great Point may now
be deemed to be the beneficial owner of 4,240,932 shares of Common Stock,
consisting of 1,595,884 shares of Common Stock and warrants to purchase
2,645,048 shares of Common Stock. Such shares, in the aggregate, represent
10.06% of Common Stock outstanding, computed in accordance with Rule 13d-3.
Great Point disclaims beneficial ownership of any securities owned by Dr. Jay.
Dr. Jay beneficially owns 90,625 shares of Common Stock, consisting of
62,500 shares of Common Stock and warrants to purchase 28,125 shares of Common
Stock. In addition, Dr. Jay, as senior managing member of Great Point, has
shared voting and investment power with respect to securities owned and held by
BMVF and BOVF and may be deemed to be the beneficial owner of such securities.
Therefore, as a result of the August 22, 2005, August 23, 2005 and August 24,
2005 sales described above, Dr. Jay may now be deemed to be the beneficial owner
of 4,331,557 shares of Common
CUSIP No. 917920 10 0 Page 7 of 8
Stock, consisting of an aggregate amount of 1,658,384 shares of Common Stock and
warrants to purchase 2,673,173 shares of Common Stock. Such shares, in the
aggregate, represent 10.27% of Common Stock outstanding, computed in accordance
with Rule 13d-3.
Notwithstanding the above, Great Point and Dr. Jay disclaim beneficial
ownership of the shares of Common Stock held by BMVF and BOVF, except to the
extent of any pecuniary interest, and this Amendment No. 3 to the Schedule 13D
shall not be deemed to be an admission that they are the beneficial owners of
such securities.
(c) The tables set forth information with respect to all sales of Common
Stock by each of BMVF and BOVF since the filing of Amendment No. 2 thereto on
July 22, 2005. Additional detail regarding such sales is included in Annex A,
Annex B and Annex C hereto, and incorporated by reference herein. All of such
sales were executed through broker's transactions on NASDAQ.
BMVF:
TRANSACTION DATE NUMBER OF SHARES AVERAGE PRICE PER SHARE
---------------- ---------------- -----------------------
August 22, 2005 1,325,000 $ 10.8615
August 22, 2005 100,000 $ 11.1757
August 23, 2005 35,500 $ 9.5625
August 24, 2005 105,500 $ 9.597
BOVF:
TRANSACTION DATE NUMBER OF SHARES AVERAGE PRICE PER SHARE
---------------- ---------------- -----------------------
August 22, 2005 475,000 $ 10.8615
August 22, 2005 100,000 $ 11.1757
August 23, 2005 35,500 $ 9.5625
August 24, 2005 105,500 $ 9.597
Item 7. Materials to be Filed as Exhibits
Annex A: Details of sales of shares by BMVF and BOVF on August 22, 2005.
Annex B: Details of sales of shares by BMVF and BOVF on August 23, 2005.
Annex C: Details of sales of shares by BMVF and BOVF on August 24, 2005.
Exhibit G: Joint Filing Agreement among Great Point, BMVF, BOVF and
Dr. Jay, dated August 25, 2005.
Except as expressly amended and supplemented hereby, the text of the
Schedule 13D remains in effect without any further modification.
CUSIP No. 917920 10 0 Page 8 of 8
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement with respect to the
undersigned is true, complete and correct.
Dated: August 25, 2005
GREAT POINT PARTNERS, LLC
/s/ Dr. Jeffrey R. Jay, M.D.
----------------------------------
By Dr. Jeffrey R. Jay, M.D., as
senior managing member
BIOMEDICAL VALUE FUND, L.P.
/s/ Dr. Jeffrey R. Jay, M.D.
---------------------------------
By Great Point Partners, LLC, as
investment manager,
By Dr. Jeffrey R. Jay as senior
managing member
BIOMEDICAL OFFSHORE VALUE FUND, Ltd.
/s/ Dr. Jeffrey R. Jay, M.D.
---------------------------------
By Great Point Partners, LLC, as
investment manager,
By Dr. Jeffrey R. Jay, M.D., as
senior managing member
DR. JEFFREY R. JAY, M.D.
/s/ Dr. Jeffrey R. Jay, M.D.
---------------------------------
ANNEX A
DETAILS OF SALES OF 1,325,000 SHARES BY BMVF ON AUGUST 22, 2005
SHARES PRICE PER SHARE
------ ---------------
2,946 $ 10.080
920 $ 10.100
368 $ 10.109
5,033 $ 10.110
5,985 $ 10.120
442 $ 10.130
1,030 $ 10.150
662 $ 10.160
291 $ 10.169
883 $ 10.180
367 $ 10.190
607 $ 10.200
158 $ 10.210
1,546 $ 10.219
1,803 $ 10.220
4,858 $ 10.229
1,472 $ 10.230
1,177 $ 10.239
736 $ 10.240
3,294 $ 10.249
5,115 $ 10.250
442 $ 10.259
3,387 $ 10.260
2,871 $ 10.269
4,564 $ 10.270
4,782 $ 10.279
6,294 $ 10.280
3,460 $ 10.289
5,421 $ 10.290
15,972 $ 10.299
10,384 $ 10.300
1,620 $ 10.309
9,457 $ 10.310
737 $ 10.319
4,747 $ 10.320
1,532 $ 10.329
4,818 $ 10.330
9,348 $ 10.339
2,517 $ 10.340
6,091 $ 10.349
18,988 $ 10.350
5,668 $ 10.359
18,497 $ 10.360
5,447 $ 10.369
8,201 $ 10.370
12,736 $ 10.379
12,145 $ 10.380
3,223 $ 10.389
3,902 $ 10.390
4,476 $ 10.399
19,352 $ 10.400
6,331 $ 10.409
4,096 $ 10.410
811 $ 10.419
1,614 $ 10.420
2,356 $ 10.429
8,907 $ 10.430
4,579 $ 10.439
4,369 $ 10.440
2,577 $ 10.449
14,789 $ 10.450
111 $ 10.459
4,785 $ 10.460
8,023 $ 10.466
6,110 $ 10.469
2,864 $ 10.470
1,225 $ 10.479
1,915 $ 10.480
4,785 $ 10.489
7,508 $ 10.490
8,097 $ 10.499
7,803 $ 10.500
5,006 $ 10.509
7,921 $ 10.510
2,138 $ 10.519
7,483 $ 10.520
9,900 $ 10.529
6,148 $ 10.530
5,742 $ 10.539
14,359 $ 10.540
4,458 $ 10.549
11,064 $ 10.550
5,595 $ 10.559
9,938 $ 10.560
1,289 $ 10.569
8,958 $ 10.570
1,399 $ 10.579
5,155 $ 10.580
1,473 $ 10.589
3,063 $ 10.590
995 $ 10.599
10,202 $ 10.600
2,209 $ 10.609
3,254 $ 10.610
1,179 $ 10.619
2,540 $ 10.620
737 $ 10.629
1,106 $ 10.630
5,589 $ 10.639
3,417 $ 10.640
5,779 $ 10.649
27,152 $ 10.650
2,430 $ 10.659
5,484 $ 10.660
479 $ 10.669
1,050 $ 10.670
7,490 $ 10.679
148 $ 10.680
2,577 $ 10.689
663 $ 10.699
47,251 $ 10.700
1,363 $ 10.709
9,056 $ 10.710
2,430 $ 10.719
19,181 $ 10.720
3,460 $ 10.729
443 $ 10.730
1,841 $ 10.739
3,313 $ 10.740
369 $ 10.749
229 $ 10.749
17,588 $ 10.750
1,105 $ 10.760
1,859 $ 10.770
148 $ 10.779
6,105 $ 10.780
8,171 $ 10.789
7,006 $ 10.790
1,841 $ 10.799
14,554 $ 10.800
2,062 $ 10.809
2,132 $ 10.810
185 $ 10.819
2,430 $ 10.820
4,417 $ 10.829
4,417 $ 10.830
75 $ 10.839
3,902 $ 10.840
19,592 $ 10.850
4,417 $ 10.859
4,417 $ 10.860
1,258 $ 10.869
4,976 $ 10.870
1,915 $ 10.879
789 $ 10.880
332 $ 10.889
1,521 $ 10.890
1,620 $ 10.899
295 $ 10.900
3,681 $ 10.910
2,209 $ 10.919
663 $ 10.920
737 $ 10.929
4,564 $ 10.939
1,620 $ 10.940
3,699 $ 10.949
847 $ 10.950
811 $ 10.959
1,605 $ 10.960
3,019 $ 10.969
1,252 $ 10.980
950 $ 10.989
12,803 $ 10.990
11,413 $ 10.999
16,437 $ 11.000
553 $ 11.009
737 $ 11.009
737 $ 11.009
369 $ 11.009
18,960 $ 11.010
3,239 $ 11.019
1,310 $ 11.020
5,061 $ 11.030
1,620 $ 11.039
515 $ 11.040
2,018 $ 11.049
11,004 $ 11.050
295 $ 11.059
7,486 $ 11.060
3,515 $ 11.069
1,031 $ 11.070
2,798 $ 11.079
3,828 $ 11.080
409 $ 11.089
4,417 $ 11.090
1,252 $ 11.099
16,019 $ 11.100
1,727 $ 11.109
1,151 $ 11.110
2,062 $ 11.119
737 $ 11.129
1,619 $ 11.130
6,094 $ 11.139
5,287 $ 11.140
147 $ 11.149
16,104 $ 11.150
736 $ 11.160
883 $ 11.169
1,325 $ 11.170
1,546 $ 11.179
4,114 $ 11.180
368 $ 11.189
37 $ 11.190
5,128 $ 11.199
18,288 $ 11.200
3,386 $ 11.209
3,378 $ 11.210
14,749 $ 11.219
6,525 $ 11.220
2,197 $ 11.229
810 $ 11.230
2,429 $ 11.239
3,827 $ 11.240
13,064 $ 11.249
39,824 $ 11.250
147 $ 11.259
6,102 $ 11.260
2,539 $ 11.269
6,392 $ 11.270
1,472 $ 11.279
442 $ 11.280
110 $ 11.289
1,156 $ 11.290
1,104 $ 11.299
3,901 $ 11.300
1,558 $ 11.320
7,875 $ 11.329
3,827 $ 11.330
6,841 $ 11.339
810 $ 11.340
6,352 $ 11.349
4,387 $ 11.350
1,030 $ 11.359
5,667 $ 11.360
4,449 $ 11.369
3,862 $ 11.370
4,004 $ 11.379
966 $ 11.380
2,208 $ 11.389
405 $ 11.390
36,012 $ 11.400
52 $ 11.410
662 $ 11.420
9,919 $ 11.430
368 $ 11.439
2,117 $ 11.440
6,698 $ 11.449
4,468 $ 11.450
3,018 $ 11.459
76 $ 11.460
4,334 $ 11.469
74 $ 11.479
4,122 $ 11.480
221 $ 11.489
2,716 $ 11.490
3,766 $ 11.500
2,208 $ 11.509
810 $ 11.510
736 $ 11.519
2,944 $ 11.520
5,226 $ 11.529
7,610 $ 11.530
2,282 $ 11.539
2,034 $ 11.540
3,963 $ 11.549
5,167 $ 11.550
1,619 $ 11.559
1,862 $ 11.560
37 $ 11.600
736 $ 11.619
1,914 $ 11.629
3,340 $ 11.700
443 $ 11.710
4,417 $ 11.719
148 $ 11.720
369 $ 11.729
737 $ 11.750
1,547 $ 11.790
737 $ 11.809
104 $ 11.820
958 $ 11.839
3,085 $ 11.900
737 $ 11.909
517 $ 11.919
76 $ 11.920
76 $ 11.929
1,839 $ 11.950
789 $ 11.960
1,250 $ 11.970
1,841 $ 11.979
2,135 $ 11.980
3,232 $ 11.990
2,798 $ 11.999
29,362 $ 12.000
DETAILS OF SALES OF 100,000 SHARES BY BMVF ON AUGUST 22, 2005
SHARES PRICE PER SHARE
------ ---------------
32,645 $ 11.00
250 $ 11.01
7,500 $ 11.05
5,307 $ 11.08
1,083 $ 11.09
1,500 $ 11.10
8,215 $ 11.12
200 $ 11.13
2,750 $ 11.14
550 $ 11.15
1,150 $ 11.20
3,500 $ 11.21
1,870 $ 11.35
4,016 $ 11.38
175 $ 11.39
1,230 $ 11.40
976 $ 11.41
1,394 $ 11.42
950 $ 11.43
600 $ 11.44
1,349 $ 11.45
50 $ 11.46
275 $ 11.47
25 $ 11.50
DETAILS OF SALES OF 475,000 SHARES BY BOVF ON AUGUST 22, 2005
SHARES PRICE PER SHARE
------ ---------------
1,054 $ 10.080
330 $ 10.100
132 $ 10.109
1,805 $ 10.110
2,145 $ 10.120
158 $ 10.130
370 $ 10.150
238 $ 10.160
105 $ 10.169
317 $ 10.180
133 $ 10.190
218 $ 10.200
56 $ 10.210
554 $ 10.219
647 $ 10.220
1,742 $ 10.229
528 $ 10.230
423 $ 10.239
264 $ 10.240
1,181 $ 10.249
1,835 $ 10.250
158 $ 10.259
1,213 $ 10.260
1,029 $ 10.269
1,636 $ 10.270
1,712 $ 10.279
2,256 $ 10.280
1,240 $ 10.289
1,943 $ 10.290
5,728 $ 10.299
3,723 $ 10.300
580 $ 10.309
3,391 $ 10.310
263 $ 10.319
1,702 $ 10.320
548 $ 10.329
1,727 $ 10.330
3,352 $ 10.339
902 $ 10.340
2,183 $ 10.349
6,810 $ 10.350
2,032 $ 10.359
6,633 $ 10.360
1,953 $ 10.369
2,940 $ 10.370
4,567 $ 10.379
4,355 $ 10.380
1,155 $ 10.389
1,398 $ 10.390
1,604 $ 10.399
6,940 $ 10.400
2,269 $ 10.409
1,468 $ 10.410
289 $ 10.419
578 $ 10.420
844 $ 10.429
3,193 $ 10.430
1,641 $ 10.439
1,566 $ 10.440
923 $ 10.449
5,303 $ 10.450
39 $ 10.459
1,715 $ 10.460
2,877 $ 10.466
2,190 $ 10.469
1,026 $ 10.470
438 $ 10.479
685 $ 10.480
1,715 $ 10.489
2,692 $ 10.490
2,903 $ 10.499
2,797 $ 10.500
1,794 $ 10.509
2,840 $ 10.510
765 $ 10.519
2,683 $ 10.520
3,550 $ 10.529
2,204 $ 10.530
2,058 $ 10.539
5,149 $ 10.540
1,598 $ 10.549
3,967 $ 10.550
2,005 $ 10.559
3,564 $ 10.560
461 $ 10.569
3,212 $ 10.570
501 $ 10.579
1,848 $ 10.580
527 $ 10.589
1,097 $ 10.590
355 $ 10.599
3,658 $ 10.600
791 $ 10.609
1,166 $ 10.610
421 $ 10.619
910 $ 10.620
263 $ 10.629
395 $ 10.630
2,004 $ 10.639
1,224 $ 10.640
2,071 $ 10.649
9,738 $ 10.650
870 $ 10.659
1,966 $ 10.660
171 $ 10.669
375 $ 10.670
2,685 $ 10.679
52 $ 10.680
923 $ 10.689
237 $ 10.699
16,948 $ 10.700
487 $ 10.709
3,247 $ 10.710
870 $ 10.719
6,879 $ 10.720
1,240 $ 10.729
157 $ 10.730
659 $ 10.739
1,187 $ 10.740
131 $ 10.749
81 $ 10.749
6,307 $ 10.750
395 $ 10.760
665 $ 10.770
52 $ 10.779
2,189 $ 10.780
2,929 $ 10.789
2,512 $ 10.790
659 $ 10.799
5,219 $ 10.800
738 $ 10.809
763 $ 10.810
65 $ 10.819
870 $ 10.820
1,583 $ 10.829
1,583 $ 10.830
25 $ 10.839
1,398 $ 10.840
7,026 $ 10.850
1,583 $ 10.859
1,583 $ 10.860
450 $ 10.869
1,783 $ 10.870
685 $ 10.879
281 $ 10.880
118 $ 10.889
544 $ 10.890
580 $ 10.899
105 $ 10.900
1,319 $ 10.910
791 $ 10.919
237 $ 10.920
263 $ 10.929
1,636 $ 10.939
580 $ 10.940
1,325 $ 10.949
302 $ 10.950
289 $ 10.959
575 $ 10.960
1,081 $ 10.969
448 $ 10.980
340 $ 10.989
4,591 $ 10.990
4,092 $ 10.999
5,895 $ 11.000
197 $ 11.009
263 $ 11.009
263 $ 11.009
131 $ 11.009
6,800 $ 11.010
1,161 $ 11.019
468 $ 11.020
1,814 $ 11.030
580 $ 11.039
185 $ 11.040
722 $ 11.049
3,946 $ 11.050
105 $ 11.059
2,684 $ 11.060
1,260 $ 11.069
369 $ 11.070
1,002 $ 11.079
1,372 $ 11.080
145 $ 11.089
1,583 $ 11.090
448 $ 11.099
5,744 $ 11.100
618 $ 11.109
411 $ 11.110
738 $ 11.119
263 $ 11.129
581 $ 11.130
2,186 $ 11.139
1,897 $ 11.140
53 $ 11.149
5,776 $ 11.150
264 $ 11.160
317 $ 11.169
475 $ 11.170
554 $ 11.179
1,476 $ 11.180
132 $ 11.189
13 $ 11.190
1,839 $ 11.199
6,560 $ 11.200
1,214 $ 11.209
1,211 $ 11.210
5,291 $ 11.219
2,340 $ 11.220
788 $ 11.229
290 $ 11.230
871 $ 11.239
1,373 $ 11.240
4,686 $ 11.249
14,285 $ 11.250
53 $ 11.259
2,189 $ 11.260
911 $ 11.269
2,293 $ 11.270
528 $ 11.279
158 $ 11.280
40 $ 11.289
414 $ 11.290
396 $ 11.299
1,399 $ 11.300
559 $ 11.320
2,825 $ 11.329
1,373 $ 11.330
2,454 $ 11.339
290 $ 11.340
2,278 $ 11.349
1,573 $ 11.350
370 $ 11.359
2,033 $ 11.360
1,596 $ 11.369
1,385 $ 11.370
1,436 $ 11.379
346 $ 11.380
792 $ 11.389
145 $ 11.390
12,918 $ 11.400
18 $ 11.410
238 $ 11.420
3,558 $ 11.430
132 $ 11.439
760 $ 11.440
2,402 $ 11.449
1,602 $ 11.450
1,082 $ 11.459
28 $ 11.460
1,554 $ 11.469
26 $ 11.479
1,478 $ 11.480
79 $ 11.489
974 $ 11.490
1,351 $ 11.500
792 $ 11.509
290 $ 11.510
264 $ 11.519
1,056 $ 11.520
1,874 $ 11.529
2,730 $ 11.530
818 $ 11.539
729 $ 11.540
1,421 $ 11.549
1,853 $ 11.550
581 $ 11.559
668 $ 11.560
13 $ 11.600
264 $ 11.619
686 $ 11.629
1,198 $ 11.700
157 $ 11.710
1,583 $ 11.719
52 $ 11.720
131 $ 11.729
263 $ 11.750
553 $ 11.790
263 $ 11.809
36 $ 11.820
342 $ 11.839
1,105 $ 11.900
263 $ 11.909
184 $ 11.919
24 $ 11.920
24 $ 11.929
661 $ 11.950
281 $ 11.960
450 $ 11.970
659 $ 11.979
765 $ 11.980
1,158 $ 11.990
1,002 $ 11.999
10,530 $ 12.000
DETAILS OF SALES OF 100,000 SHARES BY BOVF ON AUGUST 22, 2005
SHARES PRICE PER SHARE
------ ---------------
32,645 $ 11.00
250 $ 11.01
7,500 $ 11.05
5,307 $ 11.08
1,083 $ 11.09
1,500 $ 11.10
8,215 $ 11.12
200 $ 11.13
2,750 $ 11.14
550 $ 11.15
1,150 $ 11.20
3,500 $ 11.21
1,870 $ 11.35
4,016 $ 11.38
175 $ 11.39
1,230 $ 11.40
976 $ 11.41
1,394 $ 11.42
950 $ 11.43
600 $ 11.44
1,349 $ 11.45
50 $ 11.46
275 $ 11.47
25 $ 11.50
ANNEX B
DETAILS OF SALE OF 35,500 SHARES BY BMVF ON AUGUST 23, 2005
SHARES PRICE PER SHARE
------ ---------------
268 $ 9.150
10,057 $ 9.500
350 $ 9.509
1,155 $ 9.510
1,100 $ 9.529
695 $ 9.530
3,050 $ 9.550
755 $ 9.560
150 $ 9.570
1,600 $ 9.590
100 $ 9.599
5,580 $ 9.600
400 $ 9.609
3,009 $ 9.610
4,875 $ 9.619
150 $ 9.620
500 $ 9.629
65 $ 9.639
450 $ 9.650
416 $ 9.660
425 $ 9.680
350 $ 9.690
DETAILS OF SALE OF 35,500 SHARES BY BOVF ON AUGUST 23, 2005
SHARES PRICE PER SHARE
------ ---------------
267 $ 9.150
10,058 $ 9.500
350 $ 9.509
1,155 $ 9.510
1,100 $ 9.529
695 $ 9.530
3,050 $ 9.550
755 $ 9.560
150 $ 9.570
1,600 $ 9.590
100 $ 9.599
5,580 $ 9.600
400 $ 9.609
3,009 $ 9.610
4,875 $ 9.619
150 $ 9.620
500 $ 9.629
65 $ 9.639
450 $ 9.650
416 $ 9.660
425 $ 9.680
350 $ 9.690
ANNEX C
DETAILS OF SALE BY BMVF OF 105,500 SHARES ON AUGUST 24, 2005
SHARES PRICE PER SHARE
------ ---------------
1,850 $9.400
1,675 $9.410
800 $9.420
50 $9.430
900 $9.440
3,100 $9.450
1,250 $9.459
50 $9.460
25 $9.469
25 $9.479
25 $9.490
11,338 $9.500
1,950 $9.505
4,951 $9.509
4,567 $9.510
1,500 $9.519
4,440 $9.520
2,775 $9.529
2,875 $9.530
2,090 $9.539
3,538 $9.540
3,063 $9.549
3,489 $9.550
300 $9.560
343 $9.569
1,875 $9.570
952 $9.580
160 $9.589
7,329 $9.600
250 $9.609
3,204 $9.610
945 $9.619
1,262 $9.620
2,475 $9.629
144 $9.630
25 $9.640
425 $9.649
472 $9.650
1,000 $9.659
600 $9.670
250 $9.679
113 $9.680
100 $9.689
1,050 $9.690
700 $9.699
1,337 $9.700
254 $9.709
2,000 $9.710
500 $9.719
75 $9.720
2,350 $9.730
500 $9.739
718 $9.740
100 $9.749
1,568 $9.750
516 $9.759
250 $9.760
350 $9.770
1,100 $9.780
3,000 $9.789
2,925 $9.790
700 $9.799
400 $9.800
100 $9.809
500 $9.810
1,050 $9.820
100 $9.840
150 $9.859
900 $9.860
400 $9.870
2,550 $9.890
807 $9.920
DETAILS OF SALE BY BOVF OF 105,500 SHARES ON AUGUST 24, 2005
SHARES PRICE PER SHARE
------ ---------------
1,850 $9.400
1,675 $9.410
800 $9.420
50 $9.430
900 $9.440
3,100 $9.450
1,250 $9.459
50 $9.460
25 $9.469
25 $9.479
25 $9.490
11,339 $9.500
1,950 $9.505
4,950 $9.509
4,567 $9.510
1,500 $9.519
4,440 $9.520
2,775 $9.529
2,875 $9.530
2,090 $9.539
3,539 $9.540
3,062 $9.549
3,489 $9.550
300 $9.560
344 $9.569
1,875 $9.570
952 $9.580
160 $9.589
7,328 $9.600
250 $9.609
3,204 $9.610
945 $9.619
1,263 $9.620
2,475 $9.629
143 $9.630
25 $9.640
425 $9.649
473 $9.650
1,000 $9.659
600 $9.670
250 $9.679
112 $9.680
100 $9.689
1,050 $9.690
700 $9.699
1,338 $9.700
253 $9.709
2,000 $9.710
500 $9.719
75 $9.720
2,350 $9.730
500 $9.739
719 $9.740
100 $9.749
1,567 $9.750
517 $9.759
250 $9.760
350 $9.770
1,100 $9.780
3,000 $9.789
2,925 $9.790
700 $9.799
400 $9.800
100 $9.809
500 $9.810
1,050 $9.820
100 $9.840
150 $9.859
900 $9.860
400 $9.870
2,550 $9.890
806 $9.920